Oral vaccination of honeybees against varroa destructor

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

First reported in the USA, a mysterious socalled colony collapse disorder (CCD) decimated the bee colonies there between 50 and 90%. The huge global loss of honey bees as pollinators has a dramatic impact of agricultural pollination. About 130 crops, nuts, fruits, vegetables are pollinated by A.mellifera, with an overall value of more than $ 15 billion in the USA, and more than € 14 billion for the EU in 2005. In all CCD cases an overload of bloodsucking Varroa mites is detectable and Varroa is currently considered the major threat for apiculture. Honeybees possess a humoral and cellular immune system, e.g., multiple antimicrobial peptides and immune reactive enzymes. Varroa mites overcome the bee’s immune response by massive suppressing some of these immune genes. We developed a DNA vaccine for oral application which is able to reconstitute the full function of the bee’s immune system. This vaccine is absolutely biological safe, well-tolerated, show no side effects, and does not form any burden for the environment.

Cite

CITATION STYLE

APA

Giese, S., & Giese, M. (2013). Oral vaccination of honeybees against varroa destructor. In Molecular Vaccines: From Prophylaxis to Therapy-Volume 1 (pp. 269–278). Springer-Verlag Vienna. https://doi.org/10.1007/978-3-7091-1419-3_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free